Imre (US) begins Prosorba trial for kidney transplantation:
This article was originally published in Clinica
Executive Summary
Imre (US) has begun a clinical trial to evaluate the Prosorba column as a means to increase the number of patients eligible for kidney transplantation. The 15-patient study, to be carried out at the Cleveland Clinic, will determine if the Prosorba column reduces the level of sensitising antibodies which cause acute organ rejection. Imre estimates around a quarter of patients awaiting kidney transplantation are ineligible because they have developed alloantibodies to a variety of donor tissues.